Antisense oligonucleotides specific for transforming growth factor β2 inhibit the growth of malignant mesothelioma both in vitro and in vivo

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3200-3207

  Marzo, Amanda L ^a   Fitzpatrick, David R ^b   Robinson, Bruce W S ^a   Scott, Bernadette ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; DISEASE CONTROL; DNA DETERMINATION; FEMALE; GROWTH STIMULATION; IMMUNOMODULATION; LEISHMANIA BRAZILIENSIS; MESOTHELIOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TUMOR GROWTH;

ANIMALS; BROMODEOXYURIDINE; CELL DIVISION; FEMALE; INJECTIONS, INTRALESIONAL; INJECTIONS, SUBCUTANEOUS; MESOTHELIOMA; MICE; MICE, INBRED CBA; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; SURVIVAL RATE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030802978     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Massague, J. The transforming growth factor β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
2. Roberts, A. B., Kim, S. J., Kondaiah, P., Jakowlew, S. B., Denhez, F., Glick, A. B., Geiser, A. G., Watanabe, S., Noma, T., Lechleider, R., and Sporn, M. B. Transcriptional control of expression of the TGF-βs. Ann. NY Acad. Sci., 593: 43-50, 1990.
3. Massague, J. Receptors for the TGF-β family. Cell, 69: 1067-1070, 1992.
4. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F., and Massague, J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
5. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
6. Moses, H. L., Yang, E. Y., and Pietenpol, J. A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell, 63: 245-247, 1990.
7. Kerbel, R. S. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv. Cancer Res., 55: 87-132, 1990.
8. Wahl, S. M., Hunt, D. A., Wong, H. L., Dougherty, S., McCartney, F. N., Wahl, L. M., Ellingsworth, L., Schmidt, J. A., Hall, G., Roberts, A. B., and Sporn, M. B. Transforming growth factor β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol., 140: 3026-3032, 1988.
9. Barral, A., Barral, N. M., Yong, E. C., Brownell, C. E., Twardzik, D. R., and Reed, S. G. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA, 90: 3442-3446, 1993.
10. Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rude, E., and Germann, T. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin 12 and interferon-γ and is inhibited by transforming growth factor β. Eur. J. Immunol., 24: 793-798, 1994.
11. Gerwin, B. I., Lechner, J. F., Reddel, R. R., Roberts, A. B., Robbins, K. C., Gabrielson, E. W., and Harris, C. C. Comparison of production of transforming growth factor β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res., 47: 6180-6184, 1987.
12. Lauber, B., Leuthold, M., Schmitter, D., Cano, S. J., Waibel, R., and Stahel, R. A. An autocrine mitogenic activity produced by a pleural human mesothelioma cell line. Int. J. Cancer, 50: 943-950, 1992.
13. Fitzpatrick, D. R., Bielefeldt, O. H., Himbeck, R. P., Jarnicki, A. G., Marzo, A. L., and Robinson, B. W. Transforming growth factor β: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity, and tumor-infiltrating T cells in malignant mesothelioma. Growth Factors, 11: 29-44, 1994.
14. Rom, W. N., Travis, W. D., and Brody, A. R. Cellular and molecular basis of the asbestos-related diseases. Am. Rev. Respir. Dis., 143: 408-422, 1991.
15. Walker, C., Everitt, J., and Barren, J. C. Possible cellular and molecular mechanisms for asbestos carcinogenicity. Am. J. Ind. Med., 21: 253-273, 1992.